Studies in claudin-low breast cancer (17) and cervical cancer (18) also suggested that PD-L1 promotes cancer aggressiveness by influencing the tumor-intrinsic signaling events in the EMT, metabolism, and metastasis. Here, CD274 is linked to neoplasm.